Evaluation of cardiac findings in mucopolysaccharidosis

被引:2
|
作者
Dehghan, Bahar [1 ]
Rostampour, Noushin [2 ]
Sedighi, Mohsen [3 ]
Saryazdi, Mohammad Hosseini [4 ]
Rizi, Mohammad Jokar [4 ]
Mostofizadeh, Neda [2 ]
Hashemipour, Mahin [2 ]
Khoshhali, Mehri [5 ]
机构
[1] Isfahan Univ Med Sci, Cardiovasc Res Inst, Pediat Cardiovasc Res Ctr, Esfahan, Iran
[2] Isfahan Univ Med Sci, Metab Liver Dis Res Ctr, Esfahan, Iran
[3] Iran Univ Med Sci, Trauma & Injury Res Ctr, Tehran, Iran
[4] Isfahan Univ Med Sci, Sch Med, Esfahan, Iran
[5] Isfahan Univ Med Sci, Child Growth & Dev Res Ctr, Esfahan, Iran
关键词
Mucopolysaccharidoses; Children; Heart; Echocardiography; ENZYME-REPLACEMENT THERAPY; INVOLVEMENT; MORTALITY; CHILDREN;
D O I
10.1007/s10554-023-02983-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose Mucopolysaccharidoses (MPS) are a group of rare genetic diseases and heart involvement is one of the important conflicts in most types, which may cause serious complications. We used M-Mode and two-dimensional speckle tracking echocardiography (2D-STE) to explore cardiovascular involvements in MPS patients.Method The present cross-sectional study investigated the frequency of cardiac involvements in MPS patients. Included participants were MPS types I, II, III, IV, and VI who underwent specialized echocardiography exams to assess valvular function, systolic and diastolic function, left ventricular ejection fraction (LVEF), and global longitudinal strain (GLS).Results 35 patients were enrolled in this study. The total mean age of patients was 9.58 +/- 5.11 years and 71.4% were male. Type IV (40%) and type III (31.4%) were the most frequent MPS. Although LVEF did not differ notably among MPS types, GLS was significantly different (p = 0.029). Mitral regurgitation was observed remarkably more in MPS type III (p = 0.001) while mitral stenosis was more common in type III (p = 0.007). There was a significant association between LVEF and GLS (beta= -0.662; p = 0.025) and between LVEF and MPS type (beta = 1.82; p = 0.025) when adjusted for GLS.Conclusion Cardiac complications are very common and are one of the most important causes of death in MPS patients. 2D-STE seems to be superior to M-Mode for detection of early and subclinical cardiac dysfunction in MPS patients.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 50 条
  • [1] Evaluation of cardiac findings in mucopolysaccharidosis
    Bahar Dehghan
    Noushin Rostampour
    Mohsen Sedighi
    Mohammad Hosseini Saryazdi
    Mohammad Jokar Rizi
    Neda Mostofizadeh
    Mahin Hashemipour
    Mehri Khoshhali
    The International Journal of Cardiovascular Imaging, 2024, 40 : 73 - 78
  • [2] Natural history of cardiac findings in mucopolysaccharidosis type I: report from an international registry
    Braunlin, Elizabeth
    Bay, Luisa
    Guffon, Nathalie
    Yang, Meng
    Pangaud, Nicolas
    Clarke, Lorne A.
    CARDIOLOGY IN THE YOUNG, 2024, 34 (02) : 401 - 411
  • [3] Cardiac characteristics and natural progression in Taiwanese patients with mucopolysaccharidosis III
    Lin, Hsiang-Yu
    Chen, Ming-Ren
    Lin, Shan-Miao
    Hung, Chung-Lieh
    Niu, Dau-Ming
    Chang, Tung-Ming
    Chuang, Chih-Kuang
    Lin, Shuan-Pei
    ORPHANET JOURNAL OF RARE DISEASES, 2019, 14 (1)
  • [4] Evaluation of Cardiovascular Involvement and Cytokine Levels in Patients with Mucopolysaccharidosis
    Canda, Ebru
    Kose, Melis
    Kagnici, Mehtap
    Dondurmaci, Meral
    Ucar, Sema Kalkan
    Sozmen, Eser
    Levent, Resit Erturk
    Coker, Mahmut
    JOURNAL OF PEDIATRIC RESEARCH, 2019, 6 (02) : 121 - 127
  • [5] Cardiovascular findings and effects of enzyme replacement therapy in patients with mucopolysaccharidosis type VI
    Azak, Emine
    Gunduz, Mehmet
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2019, 47 (07): : 587 - 593
  • [6] The effectiveness of enzyme replacement therapy on cardiac findings in patients with mucopolysaccharidosis
    Gurbuz, Berrak Bilginer
    Aypar, Ebru
    Coskun, Turgay
    Alehan, Dursun
    Dursun, Ali
    Tokatli, Aysegul
    Sivri, Hatice Serap
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2019, 32 (10) : 1049 - 1053
  • [7] Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA
    Lin, Hsiang-Yu
    Chen, Ming-Ren
    Lin, Shan-Miao
    Hung, Chung-Lieh
    Niu, Dau-Ming
    Chuang, Chih-Kuang
    Lin, Shuan-Pei
    ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [8] Evaluation of Echocardiography and Holter Electrocardiography Findings in Patients with Mucopolysaccharidosis
    Aldudak, Bedri
    Ozbek, Mehmet Nuri
    Demirbilek, Huseyin
    Saygi, Semra
    Celik, Muhittin
    Kangin, Murat
    GUNCEL PEDIATRI-JOURNAL OF CURRENT PEDIATRICS, 2015, 13 (03): : 165 - 170
  • [9] Cerebral magnetic resonance findings during enzyme replacement therapy in mucopolysaccharidosis
    Matsubara, Yoshiko
    Miyazaki, Osamu
    Kosuga, Motomichi
    Okuyama, Torayuki
    Nosaka, Shunsuke
    PEDIATRIC RADIOLOGY, 2017, 47 (12) : 1659 - 1669
  • [10] Cerebral magnetic resonance findings during enzyme replacement therapy in mucopolysaccharidosis
    Yoshiko Matsubara
    Osamu Miyazaki
    Motomichi Kosuga
    Torayuki Okuyama
    Shunsuke Nosaka
    Pediatric Radiology, 2017, 47 : 1659 - 1669